Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Dr. C H Weaver MD
March 8, 2009
Autoimmune Disease
Dr. C H Weaver MD
March 8, 2009
S-phase Fraction (SPF)
Dr. C H Weaver MD
March 8, 2009
More Frequent Radiation Improves Survival in Stages IIIA-IIIB Cell Lung Cancer
Dr. C H Weaver MD
March 8, 2009
Docetaxel is Effective Therapy in Patients with Non Small Cell Lung Cancer
Dr. C H Weaver MD
March 8, 2009
A New Gene Therapy May Hold Promise for Non-Small Cell Lung Cancer
Dr. C H Weaver MD
March 8, 2009
Aspartame Not Linked to Brain or Blood Cancer
Dr. C H Weaver MD
March 8, 2009
Alimta® Receives Positive Endorsement for Lung Cancer Approval from FDA
Dr. C H Weaver MD
March 8, 2009
Repeated Administration of Quadramet® Safely and Effectively Relieves Bone Pain
Dr. C H Weaver MD
March 8, 2009
Provenge® for Hormone-refractory Prostate Cancer
Dr. C H Weaver MD
March 8, 2009
Treatment of Small Cell Lung Cancer with High-Dose with Peripheral Blood Stem
Dr. C H Weaver MD
March 8, 2009
Alimta Receives FDA Panel Approval for Accelerated Status in the Treatment
Dr. C H Weaver MD
March 8, 2009
Therapy For Platinum-Treated Lung Cancer: Docetaxel Shows Anti-Cancer Activity
Dr. C H Weaver MD
Previous Page
1
…
366
367
368
369
370
…
383
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
